ArticleTherapeutic advances in respiratory disease
Pulmonary tuberculosis during the developmental period contributes to COPD and pre-COPD in mid-to-late adulthood: a retrospective cohort study.
Article in Therapeutic advances in respiratory disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- γδ T Cells at the Crossroads of Tuberculosis and COPD: From Early Immunity to Tissue Remodeling.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe effect of non-smoking factors on Chronic Obstructive Pulmonary Disease (COPD) is gaining attention. Long-term contributions of pulmonary tuberculosis (PTB) during the developmental period to COPD development in later adulthood remain poorly understood.
objectivesTo investigate the impact of PTB during the developmental period of COPD and pre-COPD.
designRetrospective cohort studyMethods:This retrospective cohort study analyzed 496,534 participants using the UK Biobank cohort. PTB during the developmental period was defined as a diagnosis at age ⩽25 years. Outcomes were COPD and pre-COPD stages, including preserved ratio impaired spirometry (PRISm) and impaired spirometry (below Lower Limit of Normal (LLN) thresholds). Associations were evaluated using the multivariable logistic regression, adjusting for age, sex, body mass index, smoking, asthma, bronchiectasia, and air pollution.
resultsAmong 10,178 patients (62 (9) years old) diagnosed with COPD, PTB during the developmental period was statistically associated with increased COPD risk across four models, showing a fully adjusted odds ratio (aOR) of 1.82 (95% CI: 1.45-2.26), and remained significant regardless of sex or smoking status. Critically, PTB was also independently associated with both PRISm and airflow obstruction (aOR = 1.52, 95% CI: 1.35-1.71) and impaired spirometry below LLN (aOR = 1.32, 95% CI: 1.14-1.52). Sensitivity analyses further reinforced the robustness of these findings.
conclusionPTB during the developmental period is an independent risk factor for COPD and pre-COPD status in mid-to-late adulthood, necessitating long-term respiratory monitoring in PTB during the developmental period survivors and the implementation of targeted public health strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.